z.nakamura
TL2 · Setúbal
Contributes reviews on supplier material. Based in Setúbal.
Joined 4 April 2025 · last posted 3d
80 posts, newest first. Showing up to 150.
-
Request: a per-category review queue Replied, post #130 · Meta › Feature requests · 25 Jul 2026 · 18 likes Request: an export of my own posts. Not for any dramatic reason — I want to search my own history offline, and site search is optimised for finding other people's…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #77 · Start Here › Welcome · 24 Jul 2026 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #13 · Pharmacology › Receptor biology · 22 Jul 2026 · 13 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
Request: a per-category review queue Replied, post #79 · Meta › Feature requests · 4 Jul 2026 · 0 likes Post #76 is the version of this I will quote in future. One addition. Request with a caveat attached: a compare view for two vendor pages side by side. The caveat is…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #25 · Practice › Dosing & titration · 29 Jun 2026 · 32 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose. I…
-
Why the timeline is on the right and not the left — what changed since Replied, post #63 · Meta › Site feedback · 28 Jun 2026 · 16 likes Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific situation so staff can clarify or reconsider. That is one…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #72 · Meta › Announcements · 27 Jun 2026 · 1 like The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists.
-
Journal club: STEP 1 and the treatment-policy estimand Started this topic · Evidence › Journal club · 24 Jun 2026 · 4 likes Journal club: STEP 1 and the treatment-policy estimand Writing it up because I had to work it out twice and would rather nobody else did. Session topic: STEP 1 ( N Engl…
-
Follow-up: Reading an interaction checker output critically Replied, post #9 · Practice › Interactions · 17 Jun 2026 · 2 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #20 · Start Here › Welcome · 15 Jun 2026 · 1 like No notes. Posting so the count is not one.
-
Submitting a sample: the process end to end Replied, post #11 · Sourcing › Independent verification · 11 Jun 2026 · 26 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #64 · Access › Insurance & coverage · 7 Jun 2026 · 22 likes Appeal is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is…
-
Official shortage notices and what they authorise Replied, post #92 · Access › Shortages · 7 Jun 2026 · 6 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #96 · Sourcing › Red flags · 6 Jun 2026 · 3 likes I had written a reply contradicting post #92 and deleted it. Here is what survived. On certificate whose chromatogram axes I would separate what is worth knowing from…
-
How to ask a question when you cannot say why you are asking it Replied, post #6 · Start Here › How to Ask · 4 Jun 2026 · 22 likes Post #4 put the caveat in the right place and I want to underline it. If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse —…
-
Official shortage notices and what they authorise Replied, post #71 · Access › Shortages · 27 May 2026 · 13 likes Where I part company with post #67, and it is a narrow parting. International supply chains: a shortage in one country does not mean shortage in another. That is why…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #40 · Practice › Dosing & titration · 24 May 2026 · 0 likes Narrowing post #39, because the general version has more than one answer. Dose equivalence between different incretin analogues is a weak concept. The molecules differ…
-
What a certificate commits its issuer to — one year on Replied, post #72 · Analytics › COA interpretation · 21 May 2026 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #14 · Clinical › Special populations · 18 May 2026 · 4 likes The most useful contribution here is usually a citation to whichever published document comes closest, with a plain statement of how far it is from the question.
-
How this community labels and discusses unrefereed work — the long version Replied, post #8 · Evidence › Preprints · 11 May 2026 · 15 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
GLP-1 receptor distribution: central and peripheral Replied, post #42 · Pharmacology › Receptor biology · 2 May 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #78 · Devices › Syringes & needles · 1 May 2026 · 31 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. I have no…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #93 · Compounds › Tirzepatide · 22 Apr 2026 · 3 likes Bookmarking this. I will come back when I have something worth adding.
-
A parcel stationary at a customs facility for nine days Replied, post #49 · Sourcing › Logistics · 16 Apr 2026 · 1 like Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #30 · Sourcing › Red flags · 13 Apr 2026 · 13 likes Adding a small correction to the supplier summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
Amylin receptor signalling and satiety — what changed since Replied, post #57 · Pharmacology › Receptor biology · 6 Apr 2026 · 4 likes Amylin receptor signalling and satiety is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles…
-
EU-wide position versus national implementation — what changed since Replied, post #21 · Regional › European Union · 27 Mar 2026 · 6 likes I read post #17 twice before replying, because I had assumed the opposite. The most useful post in this subcategory is a link to the current national page in its own…
-
CJC-1295 with and without DAC: what the modification does Replied, post #21 · Compounds › Secretagogues & GH axis · 27 Mar 2026 · 0 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Revisiting: Absolute versus relative contraindications Replied, post #47 · Safety › Contraindications · 19 Mar 2026 · 0 likes Everything in post #45 holds. The case it does not cover is the one I have. What I would tell a new member reading about Absolute versus relative contraindications for…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #73 · Compounds › Cagrilintide & amylin analogues · 17 Mar 2026 · 5 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #35 · Practice › Storage & stability · 17 Mar 2026 · 5 likes Freezing a reconstituted peptide solution is not automatically protective. Freeze-thaw cycling is one of the harsher things you can do to a protein in solution, and a…
-
Oral versus injected administration claims for BPC-157 Replied, post #17 · Compounds › Repair & healing peptides · 14 Mar 2026 · 14 likes Post #16 is right about the mechanism and I think understates the practical bit. My position on oral versus injected administration claims is current rather than…
-
Micro-titration: a disputed topic, argued properly Replied, post #46 · Practice › Dosing & titration · 14 Mar 2026 · 6 likes Post #44 is right about the mechanism and I think understates the practical bit. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Started this topic · Evidence › Journal club · 27 Feb 2026 · 0 likes Journal club: SURMOUNT-4 and continuation versus withdrawal — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary…
-
Filter needles: when they help and what they cost you Replied, post #36 · Devices › Syringes & needles · 26 Jan 2026 · 28 likes Adding the measurement that post #33 says would settle it. Coring the stopper is a real phenomenon with repeated entries at the same point and blunt needles. Varying…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #19 · Practice › Storage & stability · 16 Jan 2026 · 3 likes Adsorption to container surfaces removes peptide from solution without changing how the solution looks. In dilute preparations that loss can be a meaningful proportion,…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #40 · Practice › Storage & stability · 23 Dec 2025 · 0 likes The two questions that get merged here are whether material is degraded and whether it is contaminated. Storage affects both and they need different answers and…
-
The decimal-point error, and the habit that catches it Replied, post #28 · Practice › Reconstitution · 14 Dec 2025 · 23 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #62 · Compounds › Tirzepatide · 9 Dec 2025 · 25 likes Answering the question post #58 raises rather than the one it answers. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #44 · Practice › Interactions · 5 Nov 2025 · 23 likes This settles it for me, at least until somebody posts a reason it should not.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #70 · Compounds › Tirzepatide · 22 Oct 2025 · 26 likes Where I part company with post #67, and it is a narrow parting. Weight reduction figures from SURMOUNT-1 are frequently quoted without the trial's duration attached. A…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #14 · Start Here › Welcome · 13 Oct 2025 · 25 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Cross-border purchase rules within the EU Replied, post #20 · Regional › European Union · 6 Oct 2025 · 1 like Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #135 · Access › Insurance & coverage · 26 Sep 2025 · 5 likes This follows post #134 rather than contradicting it. Where an exception process exists separately from an appeal, they are different routes with different criteria and…
-
Pages past their review date, listed Replied, post #23 · Meta › Wiki maintenance · 27 Aug 2025 · 28 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
-
Hypertension improvement and when medication needs revisiting Replied, post #22 · Clinical › Comorbidities · 24 Aug 2025 · 23 likes Post #21 is the version of this I will quote in future. One addition. Hypertension improvement has a well-known answer and a correct answer, and the interesting work is…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #73 · Evidence › Journal club · 20 Aug 2025 · 20 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
When a preprint is the best available evidence and we say so Replied, post #72 · Evidence › Preprints · 19 Aug 2025 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #42 · Compounds › Semaglutide · 15 Aug 2025 · 3 likes Answering the question post #41 raises rather than the one it answers. The strongest argument against my own position on semaglutide versus liraglutide, stated as well…
-
Gauge and length selection for subcutaneous injection Replied, post #17 · Devices › Syringes & needles · 3 Aug 2025 · 16 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #13 · Analytics › HPLC & UHPLC · 27 Jul 2025 · 0 likes Trifluoroacetic acid at 0.1 per cent is the near-universal ion-pairing additive for this work, and it also raises the baseline at 214 nanometres. That is why the same…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #2 · Practice › Side effects · 23 Jul 2025 · 17 likes Worth separating two things that the opening post runs together. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals…
-
Sequence verification for an obscure compound: how it is done Replied, post #91 · Compounds › Other compounds · 13 Jul 2025 · 1 like Sequence verification is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #36 · Sourcing › Regulatory · 28 Jun 2025 · 16 likes Distinguishing three things in the compound being unapproved discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #121 · Compounds › Tirzepatide · 27 Jun 2025 · 9 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #29 · Evidence › Trials · 12 Jun 2025 · 29 likes Picking up post #26: that is the part I would want checked first. Confounding in observational data: a third variable can explain an apparent association. In a…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #107 · Clinical › Comorbidities · 7 Jun 2025 · 6 likes Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied.
-
Research-use-only labelling: what it means and what it does not Started this topic · Sourcing › Regulatory · 31 May 2025 · 0 likes Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. A labelling…
-
Reading a chromatogram someone posted without axes Replied, post #39 · Analytics › HPLC & UHPLC · 30 May 2025 · 2 likes Detection at 214 nanometres sees the peptide bond and therefore sees almost everything peptidic. At 280 it sees aromatic residues, so a peptide without tryptophan or…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #53 · Devices › Pens & autoinjectors · 30 May 2025 · 1 like Reading the dose window rather than the dial position is worth the habit. On several devices the two do not correspond in the way you would guess. I looked this up…
-
Excipient function in a licensed injectable Replied, post #7 · Pharmacology › Formulation chemistry · 24 May 2025 · 0 likes Worth stating the null on excipient function before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #124 · Compounds › Semaglutide · 19 May 2025 · 8 likes Post #121 is right about the mechanism and I think understates the practical bit. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight…
-
Reading a trial's population section before its results — does this still hold? Replied, post #69 · Evidence › Trials · 5 May 2025 · 32 likes Post #65 describes the usual case. This is about the unusual one. Absolute and relative effects answer different questions. Write down the event rate in each arm and…
-
A well-designed study with a badly written abstract Replied, post #25 · Evidence › Study critique · 15 Apr 2025 · 21 likes Building on post #22 rather than restating it. Reporting bias within a paper — a result in a figure that is absent from the abstract — is checkable and is worth…
-
Antibiotics and a course of something with delayed emptying Replied, post #18 · Practice › Interactions · 10 Apr 2025 · 29 likes Worth separating two things that post #15 runs together. Reading back through the antibiotics threads from last year, the same three questions come up every time and…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #2 · Evidence › Journal club · 9 Apr 2025 · 8 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. The summary that goes to the digest should say what the paper establishes,…
-
Reading an MS report that only gives you a single number Replied, post #34 · Analytics › Mass spectrometry · 21 Mar 2025 · 20 likes Building on post #33 rather than restating it. The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It…
-
Maintainer handover: how it works Replied, post #64 · Meta › Wiki maintenance · 18 Mar 2025 · 15 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
-
A supplier that answers analytical questions with restated claims Replied, post #38 · Sourcing › Red flags · 12 Mar 2025 · 2 likes Picking up post #37: that is the part I would want checked first. Adding what did not work for me on supplier, since the failures never get written up and they are half…
-
Consistent declarations and why they matter more than clever ones Replied, post #60 · Sourcing › Logistics · 20 Feb 2025 · 7 likes The practical version of consistent declarations is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #43 · Pharmacology › Receptor biology · 5 Feb 2025 · 0 likes On post #41 — agreed on the reasoning, with one qualification. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in…
-
Distinguishing a deletion sequence by mass alone Replied, post #27 · Analytics › Mass spectrometry · 28 Jan 2025 · 0 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #6 · Sourcing › Vendor reports · 22 Jan 2025 · 6 likes Marking my place. If it changes for me I will come back and say so.
-
Recovery when intake is low: what to cut first Replied, post #59 · Nutrition & Training › Resistance training · 13 Jan 2025 · 32 likes Post #58 is right about the mechanism and I think understates the practical bit. On recovery, I would rather understate and be corrected upward than overstate and be…
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #28 · Clinical › Special populations · 10 Jan 2025 · 33 likes This follows post #27 rather than contradicting it. Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that need an…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #10 · Practice › Side effects · 18 Nov 2024 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #76 · Compounds › Repair & healing peptides · 17 Nov 2024 · 11 likes Post #73 is right about the mechanism and I think understates the practical bit. One more thing on reading a preclinical wound-healing model that took me far too long…
-
Progressive overload when the scale is falling — one year on Replied, post #85 · Nutrition & Training › Resistance training · 24 Sep 2024 · 1 like Strength and hypertrophy respond to different things, and preserving one during a deficit is a different objective from building the other. One more caveat and then I…
-
Transit times by route, from a logged dataset — the long version Replied, post #8 · Sourcing › Logistics · 27 Aug 2024 · 32 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Identical chromatograms across two different lots Replied, post #13 · Sourcing › Red flags · 9 Aug 2024 · 2 likes On identical chromatograms: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…